Title: Tools to improve clinical trial design in urothelial cancer
Abstract: Two reports in this issue describe a nomogram for predicting survival and a landmark analysis demonstrating the relation between 6‐month and 9‐month progression‐free status and overall survival in patients with metastatic urothelial cancer. These 2 important tools will be used to improve future clinical trial design in patients with advanced urothelial cancer.